Threshold Levels of Monocyte Chemoattractant-1 for Determining Phenotypes of Children with Cerebral Palsy

Aim of the Study. To establish threshold levels of monocyte chemoattractant -1 for determining phenotypes in children with cerebral palsy (CP). Material and Methods. The work was carried out in the period from 2018 to 2022 at the Department of Faculty Pediatrics of the Federal State Budgetary Educational Institution of Higher Education Astrakhan State Medical University of the Ministry of Health of the Russian Federation, State Budgetary Healthcare Institution of the Astrakhan Region N.N. Silishcheva Regional Children’s Clinical Hospital, and State Autonomous Institution of the Astrakhan Region Astrakhan Regional Children’s Clinical Center Rus. The study involved 128 children with different clinical forms of cerebral palsy. The level of monocyte chemoattractant1 was determined by enzyme immunoassay using a diagnostic reagent kit from Vector-Best (Novosibirsk). Statistical analysis was performed using IBM SPSS Statistics 26.0 (USA). Results and Discussion Based on the conducted examination, two phenotypes of children with cerebral palsy were distinguished. Among children of the first phenotype, higher concentrations of monocyte chemoattractant-1 in the blood serum were revealed. Thus, in patients of the first phenotype it was 2.1 (1.63; 2.99) pg/ml, which was statistically significantly (p<0.001) higher than in children of the second phenotype, 1.71 (1.44; 2.06) pg/ml. Using ROC analysis, the threshold level of monocyte chemoattractant-1 for determining belonging to the first or second phenotype was identified. It was 1.89 pg/ml. If the values exceed the specified one, the patient can be attributed to the first phenotype, with lower or equal values — to the second phenotype. CONCLUSION As a result of the conducted studies, a threshold level of MCP-1 was identified, amounting to 1.89 pg/ml. In patients of the first phenotype, possessing the most unfavorable prognostic characteristics, the values of monocyte chemoattractant-1 are higher than the specified indicator, which allows for the organization of rehabilitation measures at an earlier date. Keywords: cerebral palsy, monocyte chemoattractant, comorbid pathology> < 0.001) higher than in children of the second phenotype, 1.71 (1.44; 2.06) pg/ml. Using ROC analysis, the threshold level of monocyte chemoattractant-1 for determining belonging to the first or second phenotype was identified. It was 1.89 pg/ml. If the values exceed the specified one, the patient can be attributed to the first phenotype, with lower or equal values — to the second phenotype. Conclusion. As a result of the conducted studies, a threshold level of MCP-1 was identified, amounting to 1.89 pg/ml. In patients of the first phenotype, possessing the most unfavorable prognostic characteristics, the values of monocyte chemoattractant-1 are higher than the specified indicator, which allows for the organization of rehabilitation measures at an earlier date.